These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 35044972

  • 1. Mediators of the Effect of Corneal Cross-Linking on Visual Acuity for Fungal Ulcers: A Prespecified Secondary Analysis From the Cross-Linking-Assisted Infection Reduction Trial.
    Prajna NV, Radhakrishnan N, Lalitha P, Liu Z, Keenan JD, Arnold BF, Rose-Nussbaumer J.
    Cornea; 2022 Oct 01; 41(10):1217-1221. PubMed ID: 35044972
    [Abstract] [Full Text] [Related]

  • 2. Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis.
    Prajna NV, Radhakrishnan N, Lalitha P, Austin A, Ray KJ, Keenan JD, Porco TC, Lietman TM, Rose-Nussbaumer J.
    Ophthalmology; 2020 Feb 01; 127(2):159-166. PubMed ID: 31619359
    [Abstract] [Full Text] [Related]

  • 3. Association of Postfungal Keratitis Corneal Scar Features With Visual Acuity.
    Menda SA, Das M, Panigrahi A, Prajna NV, Acharya NR, Lietman TM, McLeod SD, Keenan JD.
    JAMA Ophthalmol; 2020 Feb 01; 138(2):113-118. PubMed ID: 31804657
    [Abstract] [Full Text] [Related]

  • 4. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
    Prajna NV, Mascarenhas J, Krishnan T, Reddy PR, Prajna L, Srinivasan M, Vaitilingam CM, Hong KC, Lee SM, McLeod SD, Zegans ME, Porco TC, Lietman TM, Acharya NR.
    Arch Ophthalmol; 2010 Jun 01; 128(6):672-8. PubMed ID: 20547942
    [Abstract] [Full Text] [Related]

  • 5. Cross-Linking Assisted Infection Reduction (CLAIR): A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Bacterial Keratitis.
    Prajna NV, Radhakrishnan N, Lalitha P, Rajaraman R, Narayana S, Austin AF, Liu Z, Keenan JD, Porco TC, Lietman TM, Rose-Nussbaumer J.
    Cornea; 2021 Jul 01; 40(7):837-841. PubMed ID: 33079921
    [Abstract] [Full Text] [Related]

  • 6. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
    Prajna NV, Krishnan T, Rajaraman R, Patel S, Shah R, Srinivasan M, Devi L, Das M, Ray KJ, O'Brien KS, Oldenburg CE, McLeod SD, Zegans ME, Acharya NR, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group.
    JAMA Ophthalmol; 2017 Jun 01; 135(6):520-525. PubMed ID: 28426856
    [Abstract] [Full Text] [Related]

  • 7. Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
    Hoffman JJ, Yadav R, Sanyam SD, Chaudhary P, Roshan A, Singh SK, Singh SK, Mishra SK, Arunga S, Hu VH, Macleod D, Leck A, Burton MJ.
    Ophthalmology; 2022 May 01; 129(5):530-541. PubMed ID: 34896126
    [Abstract] [Full Text] [Related]

  • 8. The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
    Pickel J, Narayana S, Krishnan T, Ramakrishnan S, Samantaray PP, Porco TC, Redd T, Lietman TM, Rose-Nussbaumer J.
    Am J Ophthalmol; 2020 Jul 01; 215():1-7. PubMed ID: 32171765
    [Abstract] [Full Text] [Related]

  • 9. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
    Sun CQ, Lalitha P, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM, Mycotic Ulcer Treatment Trial Group.
    Ophthalmology; 2014 Aug 01; 121(8):1495-500.e1. PubMed ID: 24746358
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quantitative evaluation of corneal irregularity and scarring after infectious keratitis using anterior segment optical coherence tomography.
    Ichikawa K, Ono T, Chen L, Kitamoto K, Taketatni Y, Toyono T, Yoshida J, Aihara M, Miyai T.
    Graefes Arch Clin Exp Ophthalmol; 2024 Jan 01; 262(1):133-141. PubMed ID: 37470808
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
    Prajna NV, Krishnan T, Rajaraman R, Patel S, Srinivasan M, Das M, Ray KJ, O'Brien KS, Oldenburg CE, McLeod SD, Zegans ME, Porco TC, Acharya NR, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial II Group.
    JAMA Ophthalmol; 2016 Dec 01; 134(12):1365-1372. PubMed ID: 27787540
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Utility of Repeat Culture in Fungal Corneal Ulcer Management: A Secondary Analysis of the MUTT-I Randomized Clinical Trial.
    Ray KJ, Lalitha P, Prajna NV, Rajaraman R, Krishnan T, Srinivasan M, Ryg P, McLeod S, Acharya NR, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group.
    Am J Ophthalmol; 2017 Jun 01; 178():157-162. PubMed ID: 28385473
    [Abstract] [Full Text] [Related]

  • 17. Relationship of Density, Depth, and Surface Irregularity of Superficial Corneal Opacification with Visual Acuity.
    Joshi VP, Chatterjee S, Basu S.
    Curr Eye Res; 2023 Jun 01; 48(6):536-545. PubMed ID: 36724802
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.